Neurocrine Biosciences Inc

VANGUARD GROUP INC NBIX

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

9,700,301

Value ($000)

1,375,794

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	1,375,794	0.0%	9,700,301	12/31/2025
2025 Q3	11/7/2025	1,362,607	0.0%	9,706,559	9/30/2025
2025 Q2	8/11/2025	1,232,650	0.0%	9,807,066	6/30/2025
2025 Q1	5/9/2025	1,099,573	0.0%	9,941,887	3/31/2025
2024 Q4	2/11/2025	1,381,331	0.0%	10,119,641	12/31/2024
2024 Q3	11/13/2024	1,151,850	0.0%	9,996,960	9/30/2024
2024 Q2	8/13/2024	1,384,471	0.0%	10,056,446	6/30/2024
2024 Q1	5/10/2024	1,369,673	0.0%	9,930,926	3/31/2024
2023 Q4	3/11/2024	1,279,433	0.0%	9,710,328	12/31/2023
2023 Q3	12/18/2023	1,075,482	0.0%	9,559,843	9/30/2023
2023 Q2	8/14/2023	902,519	0.0%	9,570,718	6/30/2023
2023 Q1	7/14/2023	971,462	0.0%	9,597,532	3/31/2023
2022 Q4	2/10/2023	1,115,605	0.0%	9,340,295	12/31/2022
2022 Q3	11/14/2022	955,992	0.0%	9,000,963	9/30/2022
2022 Q2	8/12/2022	868,008	0.0%	8,904,474	6/30/2022
2022 Q1	5/13/2022	822,887	0.0%	8,777,458	3/31/2022
2021 Q4	2/14/2022	748,473	0.0%	8,787,991	12/31/2021
2021 Q3	11/12/2021	852,493	0.0%	8,888,470	9/30/2021
2021 Q2	8/13/2021	874,383	0.0%	8,984,621	6/30/2021
2021 Q1	5/14/2021	858,647	0.0%	8,829,275	3/31/2021
2020 Q4	2/12/2021	799,128	0.0%	8,337,265	12/31/2020
2020 Q3	11/16/2020	784,813	0.0%	8,161,533	9/30/2020
2020 Q2	8/14/2020	1,034,480	0.0%	8,479,339	6/30/2020
2020 Q1	5/15/2020	735,995	0.0%	8,503,688	3/31/2020
2019 Q4	2/14/2020	893,982	0.0%	8,316,897	12/31/2019
2014 Q2	8/11/2014	32,873	0.0%	2,215,157	6/30/2014
2014 Q1	5/13/2014	35,760	0.0%	2,221,142	3/31/2014
2013 Q4	2/12/2014	17,623	0.0%	1,886,819	12/31/2013